KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $13.6 billion.

  • Vertex Pharmaceuticals' Retained Earnings rose 4115.0% to $13.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.6 billion, marking a year-over-year increase of 4115.0%. This contributed to the annual value of $13.6 billion for FY2025, which is 4115.0% up from last year.
  • Vertex Pharmaceuticals' Retained Earnings amounted to $13.6 billion in Q4 2025, which was up 4115.0% from $12.4 billion recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Retained Earnings ranged from a high of $13.6 billion in Q4 2025 and a low of $1.5 billion during Q1 2021
  • Moreover, its 5-year median value for Retained Earnings was $7.9 billion (2023), whereas its average is $7.5 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first soared by 85515.11% in 2021, then plummeted by 879.65% in 2025.
  • Vertex Pharmaceuticals' Retained Earnings (Quarter) stood at $3.2 billion in 2021, then skyrocketed by 103.79% to $6.5 billion in 2022, then skyrocketed by 55.49% to $10.1 billion in 2023, then fell by 5.28% to $9.6 billion in 2024, then skyrocketed by 41.15% to $13.6 billion in 2025.
  • Its Retained Earnings stands at $13.6 billion for Q4 2025, versus $12.4 billion for Q3 2025 and $11.3 billion for Q2 2025.